GI
TARS icon

GAMMA Investing’s Tarsus Pharmaceuticals TARS Stock Holding History

GAMMA Investing’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$27.7K Buy
352
+70
+25% +$4.86K ﹤0.01% 2746
2026
Q2 		$17.7K Sell
282
-11
-4% -$703 ﹤0.01% 2898
2026
Q1 		$20.6K Sell
293
-47
-14% -$3.28K ﹤0.01% 2698
2025
Q4 		$27.8K Buy
340
+88
+35% +$6.57K ﹤0.01% 2429
2025
Q3 		$15K Buy
252
+183
+265% +$9.01K ﹤0.01% 2669
2025
Q2 		$2.79K Sell
69
-187
-73% -$8.42K ﹤0.01% 3309
2025
Q1 		$13.2K Buy
256
+220
+611% +$10.9K ﹤0.01% 2610
2024
Q4 		$1.99K Hold
36
– – ﹤0.01% 3224
2024
Q3 		$1.18K Sell
36
-104
-74% -$2.92K ﹤0.01% 3210
2024
Q2 		$3.81K Buy
140
+8
+6% +$269 ﹤0.01% 2671
2024
Q1 		$4.8K Buy
132
+111
+529% +$3.26K ﹤0.01% 2426
2023
Q4 		$572 Buy
+21
New +$351 ﹤0.01% 2934

Other funds holding TARS

VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing's TARS Position: Q3 2026 in Review

GAMMA Investing increased its Tarsus Pharmaceuticals (TARS) stake by 25% in Q3 2026, buying an estimated $4.86K and bringing the position to 352 shares worth $27.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2746.

GAMMA Investing first reported a position in TARS in Q4 2023 and has held it in 12 quarters since. The position peaked at $27.8K in Q4 2025. 5 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

  • GAMMA Investing held 352 shares of Tarsus Pharmaceuticals worth $27.7K as of Q3 2026.
  • GAMMA Investing bought 70 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $4.86K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2746 holding.
  • GAMMA Investing first reported a position in Tarsus Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Tarsus Pharmaceuticals position peaked at $27.8K in Q4 2025.
  • 5 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.